Thus, the CD226 rs763361/Gly307Ser non-synonymous polymorphism was first correlated to type 1 diabetes susceptibility [18,19], later to multiple autoimmune diseases [19,20] and recently, to SSc [21]. Here, CD226 is linked to systemic sclerosis.